ABL ANNOUNCES DISTRIBUTION AGREEMENT WITH MEDSOL IN SAUDI ARABIA

ABL announces Distribution Agreement with Medsol in Saudi Arabia Advanced Biological Laboratories (ABL) S.A. and Medsol Corporation  are pleased to announce that they entered into an exclusive distribution agreement of ABL’s Diagnostics line of products, including the DeepChek® Assays and software, in Saudi Arabia. See current channel partners. Find us on: ABL DIAGNOSTICS   42,

ABL ANNOUNCES DISTRIBUTION AGREEMENT WITH MEDSOL IN SAUDI ARABIA Read More »

ACQUISITION OF A CONTROLLING STAKE IN ETABLISSEMENTS FAUVET GIREL BY ADVANCED BIOLOGICAL LABORATORIES

ETABLISSEMENTS FAUVET GIREL (the ” Company “) hereby informs its shareholders that STE PARISIENNE DE CONSTRUCTION ET DE LOCATION (SPACLO), holding 91.47% of the Company’s capital, and seven individuals, jointly holding 5.22% of the capital, have entered into a share purchase and sale agreement under the terms of which the transferors have sold their respective shareholdings to

ACQUISITION OF A CONTROLLING STAKE IN ETABLISSEMENTS FAUVET GIREL BY ADVANCED BIOLOGICAL LABORATORIES Read More »

ACQUISITION DU BLOC DE CONTRÔLE DE LA SOCIÉTÉ ÉTABLISSEMENTS FAUVET GIREL PAR LA SOCIÉTÉ ADVANCED BIOLOGICAL LABORATORIES S.A

La Société ETABLISSEMENTS FAUVET GIREL (la « Société ») informe ses actionnaires que la société STE PARISIENNE DE CONSTRUCTION ET DE LOCATION (SPACLO), détenant 91,47% du capital de la Société, ainsi que sept personnes physiques, détenant conjointement 5,22% du capital, ont conclu un contrat d’acquisition et de cession d’actions aux termes duquel les cédants ont cédé leurs participations

ACQUISITION DU BLOC DE CONTRÔLE DE LA SOCIÉTÉ ÉTABLISSEMENTS FAUVET GIREL PAR LA SOCIÉTÉ ADVANCED BIOLOGICAL LABORATORIES S.A Read More »

Scroll to Top